Prothena Corporation plc
DE ˙ DB ˙ IE00B91XRN20
€ 7,74 ↑0.39 (5.30%)
2026-06-04
PREÇO DA AÇÃO
SecurityDE:0PT / Prothena Corporation plc
InstitutionState Street Corp
Latest Disclosed Ownership1,674,909 shares
Ownership 3.10%
State Street Corp ownership in 0PT / Prothena Corporation plc

2024-10-18 - State Street Corp has filed an SC 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 1,674,909 shares of Prothena Corporation plc (DE:0PT). This represents 3.1 percent ownership of the company. In their previous filing dated 2024-01-24 , State Street Corp had reported owning 2,758,564 shares, indicating a decrease of -39.28 percent.

Institutional Ownership: 13D/G Filings

This table shows a history of the 13D/G filings made by the investor and/or investor group. Note that the share values in this table are not directly comparable to any numbers shown in the 13F table (if any).

File
Date
Effective
Date
Form Prev
Shares
Latest
Shares
ΔShares
(Percent)
Ownership
(Percent)
ΔOwnership
(Percent)
2024-10-18 2024-10-18 13G/A 2,758,564 1,674,909 -39.28 3.10 -39.69
2024-01-24 2024-01-24 13G 2,758,564 5.14

Important Note: One of the primary uses of the 13D/G filings is to evaluate the ability of a firm to control a company (ie, the "beneficial ownership"). To that end, firms are required to report not just direct holdings in companies, but indirect holdings that they control. For investment firms, these indirect holdings can include shares in funds they manage, advisory accounts, and in the case of activist campaigns, pledged votes. Therefore, share counts listed in 13D/G filings can differ significantly than share counts listed in 13F filings.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F PROTHENA CORP SHS G72800108 1,938,498 -329,304 -14.52 18,842 -13.00 0.0007
2026-02-13 2025-12-31 13F PROTHENA CORP SHS G72800108 2,267,802 1,366,764 151.69 21,658 146.27 0.0007
2025-11-14 2025-09-30 13F PROTHENA CORP SHS G72800108 901,038 -103,964 -10.34 8,794 44.16 0.0003
2025-08-14 2025-06-30 13F PROTHENA CORP SHS G72800108 1,005,002 -516,362 -33.94 6,100 -67.60 0.0002
2025-05-15 2025-03-31 13F PROTHENA CORP SHS G72800108 1,521,364 -340,277 -18.28 18,827 -26.98 0.0008
2025-02-14 2024-12-31 13F PROTHENA CORP SHS G72800108 1,861,641 186,732 11.15 25,784 -7.99 0.0010
2024-11-14 2024-09-30 13F PROTHENA CORP SHS G72800108 1,674,909 -257,563 -13.33 28,021 -29.75 0.0011
2024-08-14 2024-06-30 13F PROTHENA CORP SHS G72800108 1,932,472 -1,541,524 -44.37 39,886 -53.65 0.0017
2024-05-15 2024-03-31 13F PROTHENA CORP SHS G72800108 3,473,996 715,432 25.93 86,051 -14.16 0.0038
2024-02-14 2023-12-31 13F PROTHENA CORP SHS G72800108 2,758,564 648,331 30.72 100,246 -1.54 0.0049
2023-11-14 2023-09-30 13F PROTHENA CORP SHS G72800108 2,110,233 236,555 12.63 101,819 -20.41 0.0056
2023-08-14 2023-06-30 13F PROTHENA CORP SHS G72800108 1,873,678 -228,780 -10.88 127,935 25.54 0.0067
2023-05-15 2023-03-31 13F PROTHENA CORP SHS G72800108 2,102,458 50,498 2.46 101,905 -17.57 0.0058
2023-05-15 2022-12-31 13F/A-99 PROTHENA CORP SHS G72800108 2,051,960 170,166 9.04 123,631 8.36 0.0073
2023-05-15 2022-12-31 13F PROTHENA CORP SHS G72800108 2,051,960 170,166 123,631 0.0073
2022-11-15 2022-09-30 13F PROTHENA CORP SHS G72800108 1,881,794 -364,279 -16.22 114,093 87.10 0.0072
2022-08-15 2022-06-30 13F PROTHENA CORP SHS G72800108 2,246,073 -121,510 -5.13 60,981 -29.57 0.0037
2022-05-16 2022-03-31 13F PROTHENA CORP SHS G72800108 2,367,583 394,633 20.00 86,583 -11.16 0.0043
2022-02-14 2021-12-31 13F PROTHENA CORP SHS G72800108 1,972,950 567,706 40.40 97,464 -2.63 0.0046
2021-11-15 2021-09-30 13F PROTHENA CORP SHS G72800108 1,405,244 176,765 14.39 100,096 58.49 0.0053
2021-08-16 2021-06-30 13F PROTHENA CORP SHS G72800108 1,228,479 24,187 2.01 63,156 108.77 0.0033
2021-07-09 2021-03-31 13F/A-1 PROTHENA CORP SHS G72800108 1,204,292 594,142 97.38 30,252 312.83 0.0017
2021-05-17 2021-03-31 13F PROTHENA CORP SHS G72800108 1,204,292 594,142 30,252 0.0017
2021-02-16 2020-12-31 13F PROTHENA CORP SHS G72800108 610,150 -623,301 -50.53 7,328 -40.53 0.0004
2020-11-10 2020-09-30 13F PROTHENA CORP SHS G72800108 1,233,451 -204,174 -14.20 12,322 -18.06 0.0008
2020-08-14 2020-06-30 13F PROTHENA CORP SHS G72800108 1,437,625 384,177 36.47 15,038 33.41 0.0011
2020-06-19 2020-03-31 13F/A-1 PROTHENA CORP SHS G72800108 1,053,448 15,176 1.46 11,272 -31.42 0.0010
2020-05-11 2020-03-31 13F PROTHENA CORP SHS G72800108 1,053,448 15,176 11,272 989.9086
2020-02-06 2019-12-31 13F PROTHENA CORP SHS G72800108 1,038,272 -158,351 -13.23 16,436 75.19 0.0011
2019-11-14 2019-09-30 13F PROTHENA CORP SHS G72800108 1,196,623 -184,789 -13.38 9,382 -35.75 0.0007
2019-08-14 2019-06-30 13F PROTHENA CORP SHS G72800108 1,381,412 -140,388 -9.23 14,602 -20.89 0.0011
2019-05-15 2019-03-31 13F PROTHENA CORP SHS G72800108 1,521,800 -1,371 -0.09 18,459 17.66 0.0014
2019-02-12 2018-12-31 13F PROTHENA CORP SHS G72800108 1,523,171 -409,827 -21.20 15,689 -37.94 0.0014
2018-11-09 2018-09-30 13F PROTHENA CORP Common equity shares G72800108 1,932,998 -1,488,475 -43.50 25,281 -49.32 0.0019
2018-08-14 2018-06-30 13F PROTHENA CORP Common equity shares G72800108 3,421,473 1,674,378 95.84 49,881 -22.23 0.0042
2018-05-15 2018-03-31 13F PROTHENA CORP Common equity shares G72800108 1,747,095 358,674 25.83 64,136 23.22 0.0054
2018-02-14 2017-12-31 13F PROTHENA CORP Common equity shares G72800108 1,388,421 183,195 15.20 52,049 -33.32 0.0042
2017-11-14 2017-09-30 13F PROTHENA CORP Common equity shares G72800108 1,205,226 23,861 2.02 78,055 22.09 0.0067
2017-08-14 2017-06-30 13F PROTHENA CORP Common equity shares G72800108 1,181,365 113,193 10.60 63,932 7.28 0.0057
2017-05-15 2017-03-31 13F PROTHENA CORP Common equity shares G72800108 1,068,172 -17,239 -1.59 59,594 11.62 0.0053
2017-02-09 2016-12-31 13F PROTHENA CORP Common equity shares G72800108 1,085,411 13,694 1.28 53,392 -16.93 0.0050
2017-01-13 2016-09-30 13F/A-1 PROTHENA CORP Common equity shares G72800108 1,071,717 139,364 14.95 64,272 97.21 0.0065
2016-11-14 2016-09-30 13F PROTHENA CORP Common equity shares G72800108 1,071,717 64,272
2016-08-12 2016-06-30 13F PROTHENA CORP Common equity shares G72800108 932,353 -292,170 -23.86 32,590 -35.34 0.0035
2016-05-20 2016-03-31 13F/A-1 PROTHENA CORP Common equity shares G72800108 1,224,523 415,089 51.28 50,406 -8.57 0.0054
2016-05-12 2016-03-31 13F PROTHENA CORP Common equity shares G72800108 1,224,523 50,406
2016-02-16 2015-12-31 13F PROTHENA CORP Common equity shares G72800108 809,434 -159,371 -16.45 55,130 25.51 0.0060
2015-11-16 2015-09-30 13F PROTHENA CORP Common equity shares G72800108 968,805 -97,172 -9.12 43,925 -21.76 0.0051
2015-08-13 2015-06-30 13F PROTHENA CORP Common equity shares G72800108 1,065,977 -123,599 -10.39 56,143 23.76 0.0060
2015-05-15 2015-03-31 13F PROTHENA CORP Common equity shares G72800108 1,189,576 39,879 3.47 45,366 90.10 0.0047
2015-02-11 2014-12-31 13F PROTHENA CORP Common equity shares G72800108 1,149,697 134,060 13.20 23,864 6.03 0.0024
2014-11-12 2014-09-30 13F/A-1 PROTHENA CORP Common equity shares G72800108 1,015,637 116,268 12.93 22,506 10.97 0.0024
2014-11-10 2014-09-30 13F PROTHENA CORP Common equity shares G72800108 1,015,637 22,506
2014-08-12 2014-06-30 13F PROTHENA CORP Common equity shares G72800108 899,369 680,869 311.61 20,281 142.28 0.0022
2014-05-15 2014-03-31 13F/A-1 PROTHENA CORP Common equity shares G72800108 218,500 23,421 12.01 8,371 61.91 0.0010
2014-05-13 2014-03-31 13F PROTHENA CORP Common equity shares G72800108 218,600 8,375
2014-02-06 2013-12-31 13F/A-1 PROTHENA CORP Common equity shares G72800108 195,079 43,073 28.34 5,170 68.35 0.0006
2014-02-06 2013-12-31 13F PROTHENA CORP Common equity shares G72800108 258,358 1,889
2013-11-12 2013-09-30 13F PROTHENA CORP Common equity shares G72800108 152,006 31,966 26.63 3,071 98.39 0.0004
2013-08-08 2013-06-30 13F PROTHENA CORP Common equity shares G72800108 120,040 120,040 1,548 0.0002
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.